Heart Safety vs Heart Benefit: What a New Weight-Care Trial Really Showed A November 2026 Lancet trial found a newer, not yet approved weekly weight-care medicine did not raise major heart events versus placebo (hazard ratio 0.89, range 0.67 to 1.18). That shows safety, not benefit. About 1 in 5 people stopped because of stomach side effects (19.3% and 20.8% vs 1.9% on placebo), mostly while doses were being raised. Education only; a licensed provider decides every treatment. Why do people stop weight loss medication? Stomach side effects are a common reason. In a November 2026 Lancet trial of a newer weight-care medicine, about 1 in 5 people stopped for that reason, mostly while doses were going up. HOO Longevity in the United States connects you with a licensed provider who sets a steady pace and checks in along the way. Sources: The Lancet, 2026: https://www.ajmc.com/view/survodutide-meets-cv-safety-end-point-in-synchronize-cvot Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #weightcare #metabolichealth #healthyhabits #Shorts #HOOLongevityAcademy #JoinHOOHealth